What is the Optimal Time for PSMA Radioligand Therapy? “Presentation” – Oliver Sartor
At the 2024 UCSF-UCLA PSMA Conference, Oliver Sartor advocates for the early use of PSMA radioligand therapy in prostate cancer treatment, challenging the traditional reliance on castration and chemotherapy due to their significant side effects. Dr. Sartor urges a shift in evaluating therapy efficacy, focusing on patient preference and practical decision-making in clinical settings, and calls…